← FDA Drug Approvals (Drugs@FDA)
DROSPIRENONE AND ESTRADIOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2025-10-28
Drug application
- FDA Application #
ANDA218031- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DROSPIRENONE AND ESTRADIOL
- Generic name
- Drospirenone
- Active ingredients
- DROSPIRENONE; ESTRADIOL
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- First approval
- 2025-10-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown